Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Sugen initiates phase II prostate cancer trial with SU-101

Dec. 5, 1997

Genta to evaluate G-3139 in U.S. prostate cancer trial

Dec. 5, 1997

Fareston launched in U.S. for metastatic breast cancer

Dec. 4, 1997

Agouron, Roche terminate cancer collaboration; AG-337 development discontinued

Dec. 4, 1997

MDR modulators prepared at Janssen

Dec. 4, 1997

Single injections of RC-3095 produce prolonged reductions in EGF receptor number and expression

Dec. 4, 1997

Miravant reports promising interim phase III results for breast cancer trial

Dec. 4, 1997

Pfizer discontinues collaboration with Megabios

Dec. 3, 1997

VEGF receptor tyrosine kinase inhibitors under development at Zeneca

Dec. 3, 1997

Water-soluble taxanes reported in patent literature

Dec. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...